3MEBAZAA A. Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults-are there differences? [J]. Pol Arch Med Wewn, 2009, 119(9) : 569-573.
4LIU W, MUKKU K, GILANI S, et al. Percutaneous hemodynamic support (Impella) in patients with advanced heart failure and/or cardiogenic shock not eligible to PROTECT IItriM[J]. Int J Angiol, 2013, 22(4) : 207-212.
5SOBIESKI M A, GIRIDHARAN G A, ISING M, et al. Blood trauma testing of CentriMag and RotaFlow centrifugal flow devices: a pilot study[J]. Artif Organs, 2012, 36(8): 677- 682.
6SASTRY A. Overview of the US FDA medical device approval process[J]. Curr Cardiol Rep, 2014, 16(6) : 494.
7JAHANMIR S, HUNSBERGER A Z, HESHMAT H, et al. Performance characterization of a rotary centrifugal left ventricular assist device with magnetic suspension [ J ]. Artif Organs, 2008, 32(5): 366-375.
8SONG X, THROCKMORTON A L, UNTAROIU A, et al. Axial flow blood pumps[J]. ASAIO J, 2003, 49(4): 355- 364.
9JOHNSON C J, VANDENBERGHE S, DALY A R, et al. Bioeompatibility assessment of the first generation PediaFlow pediatric ventricular assist device[ J]. Artif Organs, 2011, 35 (1): 9-21.
10SIESS T, NIX C, MENZLER F. From a lab type to a product: a retrospective view on Impella's assist technology [J].Artif Organs, 2001, 25(5): 414-421.
